Researchers developed an RNA-based switch, the pA regulator system, to control gene expression in mammalian cells by modulating synthetic polyA signal cleavage, offering a novel approach for gene therapy applications.
Risk Adjusted Net Present Value: What is the current valuation of Hutchmed China’s Amdizalisib
The revenue for Amdizalisib is expected to reach an annual total of $24 mn by 2033 globally based off GlobalData’s Expiry Model. The drug’s revenue
May 16, 2024